Depression and coronary heart disease
Robert M Carney1, Kenneth E Freedland1
1Washington University School of Medicine, 4320 Forest Park Avenue, Suite 301, St. Louis, Missouri 63108, USA.
Insights
Depression significantly increases coronary heart disease (CHD) risk. While treating depression hasn't improved cardiac outcomes, improved depression suggests better patient prognosis.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depression is a major risk factor for coronary heart disease (CHD) and adverse cardiovascular outcomes.
- Hypothesized biobehavioral mechanisms linking depression and CHD explain only a small portion of the risk.
- Few clinical trials have investigated if depression treatment improves cardiac events in CHD patients.
Purpose of the Study:
- To review the evidence on the relationship between depression and coronary heart disease (CHD).
- To assess the impact of depression treatment on cardiac outcomes in patients with established CHD.
- To identify future research directions for understanding and managing depression in CHD.
Main Methods:
- Review of existing clinical trials and secondary analyses examining depression treatment in CHD patients.
- Analysis of hypothesized biological and behavioral mechanisms linking depression to CHD.
- Synthesis of current evidence to guide future research and clinical practice.
Main Results:
- Current depression treatments have not demonstrated improved cardiac outcomes in patients with established CHD.
- Secondary analyses suggest a potential link between improved depression and better patient prognosis.
- The direct impact of depression treatment on cardiac events remains inconclusive.
Conclusions:
- More potent depression interventions are needed for patients with CHD.
- Identifying high-risk depression subtypes may improve targeted treatment efficacy.
- Further research into biobehavioral mechanisms is crucial for definitive clinical trials.
Abstract:
Depression is a highly prevalent risk factor for incident coronary heart disease (CHD) and for cardiovascular morbidity and mortality in patients with established CHD. Several biological and behavioural mechanisms have been hypothesized to underlie the relationship between depression and CHD, but none has been shown to account for more than a small proportion of the risk. Only a few clinical trials have examined whether treating depression decreases the risk of cardiac events in patients with established CHD. None of these trials has shown that treatment results in improved cardiac outcomes, but the differences in depression outcomes between the intervention and control groups have been small and not clinically significant. Nevertheless, secondary analyses of these trials suggest that prognosis improves when depression improves. Concerted efforts to develop more potent interventions for depression, identification of high-risk subtypes of depression, and further research on the biobehavioural mechanisms linking depression to CHD are needed to pave the way for definitive clinical trials.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Depressive Disorders: MDD and Dysthymia


